MS AI Stock Analysis – Buy, Hold, or Avoid?
Morgan Stanley (MS)
Morgan Stanley (MS) is exhibiting robust growth in revenue and earnings, expanding margins, and strong technical momentum near its 52-week highs. While valuation is at a premium, it is justified by superior fundamentals and positive sentiment, with manageable risks and a favorable risk/reward profile for disciplined investors. All agents point to continued upside, especially for medium- and long-term horizons, though short-term traders should watch for resistance near $195.
Fundamentals
Morgan Stanley demonstrates robust financial fundamentals, marked by strong sequential and year-over-year growth in both revenue and earnings. Margins, profitability metrics, and consistent outperformance on earnings estimates highlight management's execution prowess and the firm's sustained business momentum.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
18.77% YoY
Q1 2026
Net Income
30.66% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.1B | 28.9B | 30.0B | 28.2B | 27.9B | 26.0B | 26.3B | 25.5B |
| Revenue Growth YoY | +18.77% | +11.08% | +14.13% | +10.50% | +10.11% | +7.40% | +16.67% | +18.62% |
| Net Income | 5.6B | 4.4B | 4.6B | 3.5B | 4.3B | 3.7B | 3.2B | 3.1B |
| Net Income Growth YoY | +30.66% | +18.39% | +44.60% | +15.05% | +26.47% | +144.83% | +32.39% | +40.97% |
| EPS | $3.44 | $2.71 | $2.83 | $2.15 | $2.62 | $2.25 | $1.91 | $1.85 |
| EPS Growth YoY | +31.30% | +20.44% | +48.17% | +16.22% | +28.43% | +161.63% | +37.41% | +48.00% |
Profitability Metrics
Gross Margin
TTM
Operating Margin
TTM
Net Margin
TTM
Return on Equity
TTM
Return on Assets
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.79% | 58.02% | 56.85% | 54.71% | 58.69% | 57.46% | 54.16% | 54.73% |
| Operating Margin | 21.15% | 19.96% | 20.06% | 16.41% | 19.86% | 18.88% | 16.03% | 15.99% |
| Net Margin | 17.01% | 15.24% | 15.34% | 12.57% | 15.46% | 14.29% | 12.11% | 12.07% |
| Return on Equity (ROE) | 4.93% | 3.94% | 4.19% | 3.27% | 4.04% | 3.55% | 3.08% | 3.05% |
| Return on Assets (ROA) | 0.36% | 0.31% | 0.34% | 0.27% | 0.34% | 0.31% | 0.26% | 0.26% |
Technical Analysis
Morgan Stanley (MS) is currently in a strong uptrend, trading near its 52-week high with robust support from moving averages and a strong ADX reading. Momentum remains positive with RSI in a neutral zone, suggesting room for further upside without overbought conditions. Technical patterns indicate institutional accumulation and a buy-friendly advancing phase.
No extreme reading
Price in uptrend
Strong trend active
50 above 200 - bullish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Morgan Stanley demonstrates robust financial fundamentals, marked by strong sequential and year-over-year growth in both revenue and earnings. Margins, profitability metrics, and consistent outperformance on earnings estimates highlight management's execution prowess and the firm's sustained business momentum.
Latest Earnings
Q1 2026 Earnings (Mar 31, 2026)
Earnings Per Share (EPS)
Actual
$3.43
Estimated
$3.02
Surprise
+$0.41
Surprise %
+13.58%
Revenue
Actual
$20.58B
Estimated
$19.74B
Surprise
+$841.53M
Surprise %
+4.26%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $3.43 | $2.68 | $2.80 | $2.13 | $2.60 | $2.22 | $1.88 | $1.82 |
| EPS (Estimated) | $3.02 | $2.43 | $2.10 | $1.98 | $2.21 | $1.62 | $1.58 | $1.65 |
| EPS Surprise | +$0.41 | +$0.25 | +$0.70 | +$0.15 | +$0.39 | +$0.60 | +$0.30 | +$0.17 |
| % Diff | +13.6% | +10.3% | +33.3% | +7.6% | +17.6% | +37.0% | +19.0% | +10.3% |
| Revenue | ||||||||
| Revenue (Actual) | $20.58B | $17.89B | $17.08B | $15.6B | $16.52B | $15.04B | $14.34B | $14.02B |
| Revenue (Estimated) | $19.74B | $17.74B | $16.69B | $16.07B | $16.54B | $15.03B | $14.35B | $14.32B |
| Revenue Surprise | +$841.53M | +$148.84M | +$394.92M | -$461.94M | -$20.16M | +$16.73M | -$12.25M | -$297.77M |
| % Diff | +4.3% | +0.8% | +2.4% | -2.9% | -0.1% | +0.1% | -0.1% | -2.1% |
Valuation
Morgan Stanley exhibits robust financial performance backed by strong revenue and earnings growth alongside solid returns on equity. Valuation metrics suggest the stock is trading at a premium relative to some traditional measures but is supported by growth in institutional securities and wealth management segments. Analyst sentiment is moderately bullish with price targets indicating modest upside potential from current levels.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 11.46 | 15.86 | 13.54 | 15.69 | 10.71 | 13.40 | 12.98 | 12.85 |
| Price to Sales | 7.80 | 9.66 | 8.31 | 7.89 | 6.62 | 7.66 | 6.29 | 6.20 |
| Price to Book | 2.26 | 2.50 | 2.27 | 2.05 | 1.73 | 1.90 | 1.60 | 1.57 |
| Enterprise Value to EBITDA | 74.06 | 93.18 | 80.11 | 92.76 | 81.28 | 73.85 | 87.13 | 85.12 |
| Enterprise Value to Revenue | 15.66 | 22.27 | 19.66 | 19.53 | 18.66 | 18.62 | 18.17 | 17.85 |
Sentiment & Analyst Ratings
Morgan Stanley's market sentiment is predominantly positive, supported by strong quarterly earnings growth and a solid analyst consensus rating favoring moderate buy or buy recommendations. While some short-term profit-taking has tempered investor enthusiasm, the overall outlook reflects confidence in continued revenue momentum driven by institutional securities and wealth management segments.
Analyst Recommendations
Risk Assessment
Morgan Stanley demonstrates solid short-term liquidity and an improving financial position, although it carries substantial leverage typical for its financial sector. Macroeconomic and regulatory conditions in 2026 present a cautiously optimistic outlook with opportunities in AI-driven growth, but the firm faces risks from geopolitical tensions and evolving financial regulations. Investor sentiment remains generally positive with a moderate upside potential, balanced by manageable risks in a complex market environment.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q1 2026
Quick Ratio
Latest Quarter: Q1 2026
Debt-to-Equity
Latest Quarter: Q1 2026
Debt-to-Assets
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 1.61 | 1.17 | 0.26 | 0.45 | 0.22 | 0.66 | 0.68 | 0.64 |
| Quick Ratio | 1.61 | 1.17 | 0.26 | 0.45 | 0.22 | 0.66 | 0.68 | 0.64 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 3.45 | 4.26 | 3.77 | 4.04 | 3.72 | 3.45 | 3.61 | 3.55 |
| Debt-to-Assets | 0.25 | 0.33 | 0.30 | 0.32 | 0.31 | 0.30 | 0.30 | 0.30 |
Liquidity Assessment
Current Ratio: 1.61(Strong)
Quick Ratio: 1.61(Strong)
The company has strong liquidity with sufficient short-term assets to cover liabilities.
Solvency Assessment
Debt-to-Equity: 3.45(High)
Debt-to-Assets: 0.25(Low)
The company has relatively high debt levels, which may increase financial risk in economic downturns.
Frequently Asked Questions about MS
AI Answers: Common Questions About MS
Get AI-powered answers to the questions investors ask most about Morgan Stanley
Morgan Stanley is a good buy for medium- and long-term investors, given its strong fundamentals (Q1 2026 EPS up 33% YoY, gross margin 61.7%), justified premium valuation (P/E 17.68), and bullish technicals. The current price of $193.04 is just below resistance, so short-term traders may want to wait for a breakout or pullback, but the overall outlook remains positive.
There is no compelling reason to sell unless you are a short-term trader aiming to lock in profits near resistance at $194.83. Fundamentals remain strong, technicals are bullish, and sentiment is positive; only those with a very short-term focus or low risk tolerance should consider trimming.
The biggest risks are high leverage (debt/equity ~3.45), sensitivity to interest rate changes and macroeconomic downturns, and potential regulatory shifts. While liquidity ratios are strong (current and quick ratio ~1.6), a sharp market downturn or regulatory tightening could pressure margins and earnings.
Analyst consensus targets average $204, while technical resistance is at $194.83; a breakout could see upside toward $200-210. Support is strong at $173.90 (50-day SMA) and $166.99 (200-day SMA), providing a favorable risk/reward setup.
MS is fairly valued at a P/E of 17.68 and elevated EV/EBITDA, reflecting justified optimism for future growth. While trading at a premium to sector averages, this is warranted by superior margins, ROE, and earnings momentum.
Fundamentals are excellent: revenue up 11.5% YoY (FY25), Q1 2026 EPS up 33% YoY, gross margin at 61.7%, and ROE in the mid-to-high teens. The business is diversified, with recurring fee streams and strong risk management.
Technicals are bullish: price is above all key moving averages, golden cross is active, ADX >32 confirms trend strength, and RSI at 63 shows momentum without overbought risk. Watch for a breakout above $195 for further upside.
Key catalysts include upcoming earnings reports, a breakout above $195 resistance, continued strength in wealth management and AI-driven business lines, and any regulatory relief or macroeconomic tailwinds.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.